NCT00685958View on ClinicalTrials.gov

Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Hip Fractures
Interventions
DRUG

enoxaparin (XRP4563)

14 days of treatment

Trial Locations (1)

Unknown

Sanofi- Aventis Administrative Office, Tokyo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00685958 - Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery | Biotech Hunter | Biotech Hunter